top of page

Name, Title


David Glickman
Strategic Advisor | Resilience Capital Partners
Executive Director - Investments | GlobalGuard IT

The American Cancer Society’s Greater Cleveland Golf Classic, presented by Metro Lexus & Lexus of Akron-Canton, is excited to share David Glickman has been named 2024 Honorary Chair & Dr. Alex Adjei has been named our 2024 Honoree. On behalf of the American Cancer Society, our Executive and Trustee committees, and cancer patients everywhere, we thank David Glickman and Dr. Adjei for all they have done and will do to end cancer as we know it for everyone!

background strip canva.jpg

2024 Greater Cleveland Golf Classic Honorary Chair & Honoree


Dr. Alex A. Adjei
Chief of Cleveland Clinic Cancer Institute & Director of the Taussig Cancer Center | Cleveland Clinic



Alex A. Adjei, MD, PhD, FACP, FASCO, is Chief of Cleveland Clinic Cancer Institute, overseeing cancer care and research across all Cleveland Clinic locations in Ohio, Florida, Abu Dhabi, and London. He is also the director of the Taussig Cancer Center in Cleveland and the M. Frank Rudy and Margaret D. Rudy Distinguished Chair in Translational Cancer Research at Cleveland Clinic.

Dr. Adjei graduated with his medical degree from the University of Ghana Medical School in Accra, Ghana and received his PhD from the University of Alberta in Edmonton, Canada. He went on to complete his residency and was Chief Resident at Howard University. Following that, Dr. Adjei went on to complete a Clinical and Research Fellowship in Oncology at John Hopkins University School of Medicine and Hospital.

Previously, Dr. Adjei served as Professor of Oncology and Professor of Pharmacology and Director of Early Cancer Therapeutics at Mayo Clinic and Mayo Clinic College of Medicine and Science in Rochester, Minnesota. Prior to this role, Dr. Adjei was the Senior Vice President of Clinical Research, Chairman of the Department of Medicine, and Professor of Oncology at the Roswell Park Cancer Institute in Buffalo, New York. He was also Academic Scholar in Medicine and Professor of Medicine at the State University of New York, Buffalo.

Dr Adjei has served on a number of US National Cancer Institute (NCI) committees. From 2007 to 2013, he was Chair of the NIH Study Section NCRR Clinical Research Review Committee, reviewing CTSAs. From 2010-2014, he was a Member of the Clinical Oncology Study Section (CONC), and from 2013-2017, he was a member of NCI IRG Subcommittee A, reviewing Cancer Centers. He was co-chair of the Thoracic Malignancies Steering Committee of NCI from 2015 to 2021.. Dr Adjei has served on the Committee on Diagnosing and Treating Adult Cancers of the US National Academies of Sciences, Engineering and Medicine, tasked with providing a report on this topic to the US government (Social Security Administration). Previously, he was President of the Minorities in Cancer Research Council of the American Association for Cancer Research, as well as a member of the Board of Directors of the International Association for the Study of Lung Cancer. He is currently a member of the NCI Board of Scientific Counselors.

Among numerous awards and honors, Dr. Adjei has received the Adi F. Gazdar Merit Award from the International Association for the Study of Lung Cancer for Distinguished Achievement in Lung Cancer Research and Mentorship, the ESMO Lifetime achievement award, and the ASCO Drug Development Research Professorship for his work in drug development, regulatory science and for his mentorship

Dr. Adjei has focused his research on experimental therapeutics, regulatory science and clinical drug development. Other research interests include health disparities, global oncology, and pharmacogenetics.  He has published over 300 peer-reviewed articles, and is editor-in-chief of the Journal of Thoracic Oncology and the JTO Clinical and Research Reports.

bottom of page